111 related articles for article (PubMed ID: 8833282)
1. Dosimetry model for photodynamic therapy with topically administered photosensitizers.
Svaasand LO; Wyss P; Wyss MT; Tadir Y; Tromberg BJ; Berns MW
Lasers Surg Med; 1996; 18(2):139-49. PubMed ID: 8833282
[TBL] [Abstract][Full Text] [Related]
2. A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen.
Liu B; Farrell TJ; Patterson MS
Phys Med Biol; 2010 Oct; 55(19):5913-32. PubMed ID: 20844331
[TBL] [Abstract][Full Text] [Related]
3. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
[TBL] [Abstract][Full Text] [Related]
4. Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer.
van den Akker JT; de Bruijn HS; Beijersbergen van Henegouwen GM; Star WM; Sterenborg HJ
Photochem Photobiol; 2000 Sep; 72(3):399-406. PubMed ID: 10989612
[TBL] [Abstract][Full Text] [Related]
5. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma.
Dögnitz N; Salomon D; Zellweger M; Ballini JP; Gabrecht T; Lange N; van den Bergh H; Wagnières G
J Photochem Photobiol B; 2008 Dec; 93(3):140-8. PubMed ID: 18818091
[TBL] [Abstract][Full Text] [Related]
7. Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice.
van der Veen N; de Bruijn HS; Berg RJ; Star WM
Br J Cancer; 1996 Apr; 73(7):925-30. PubMed ID: 8611408
[TBL] [Abstract][Full Text] [Related]
8. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment.
Martin A; Tope WD; Grevelink JM; Starr JC; Fewkes JL; Flotte TJ; Deutsch TF; Anderson RR
Arch Dermatol Res; 1995; 287(7):665-74. PubMed ID: 8534131
[TBL] [Abstract][Full Text] [Related]
9. 5-Aminolevulinic acid coated microneedles for photodynamic therapy of skin tumors.
Jain AK; Lee CH; Gill HS
J Control Release; 2016 Oct; 239():72-81. PubMed ID: 27543445
[TBL] [Abstract][Full Text] [Related]
10. Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy.
Oh EK; Jin SE; Kim JK; Park JS; Park Y; Kim CK
Eur J Pharm Sci; 2011 Sep; 44(1-2):149-57. PubMed ID: 21782942
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy.
Fang YP; Tsai YH; Wu PC; Huang YB
Int J Pharm; 2008 May; 356(1-2):144-52. PubMed ID: 18325699
[TBL] [Abstract][Full Text] [Related]
12. Systemic component of protoporphyrin IX production in nude mouse skin upon topical application of aminolevulinic acid depends on the application conditions.
van den Akker JT; Iani V; Star WM; Sterenborg HJ; Moan J
Photochem Photobiol; 2002 Feb; 75(2):172-7. PubMed ID: 11885562
[TBL] [Abstract][Full Text] [Related]
13. Photobleaching during and re-appearance after photodynamic therapy of topical ALA-induced fluorescence in UVB-treated mouse skin.
Van der Veen N; De Bruijn HS; Star WM
Int J Cancer; 1997 Jul; 72(1):110-8. PubMed ID: 9212231
[TBL] [Abstract][Full Text] [Related]
14. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment.
Ross EV; Romero R; Kollias N; Crum C; Anderson RR
Br J Dermatol; 1997 Nov; 137(5):736-42. PubMed ID: 9415233
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825
[TBL] [Abstract][Full Text] [Related]
16. A quantitative study of in vivo protoporphyrin IX fluorescence build up during occlusive treatment phases.
Campbell CL; Brown CTA; Wood K; Salvio AG; Inada NM; Bagnato VS; Moseley H
Photodiagnosis Photodyn Ther; 2017 Jun; 18():204-207. PubMed ID: 28257944
[TBL] [Abstract][Full Text] [Related]
17. Quantitative model calculation of the time-dependent protoporphyrin IX concentration in normal human epidermis after delivery of ALA by passive topical application or lontophoresis.
Star WM; Aalders MC; Sac A; Sterenborg HJ
Photochem Photobiol; 2002 Apr; 75(4):424-32. PubMed ID: 12003134
[TBL] [Abstract][Full Text] [Related]
18. Effect of (R)L-sulforaphane on 5-aminolevulinic acid-mediated photodynamic therapy.
Mikolajewska P; Juzeniene A; Moan J
Transl Res; 2008 Sep; 152(3):128-33. PubMed ID: 18774542
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model.
Maisch T; Santarelli F; Schreml S; Babilas P; Szeimies RM
Exp Dermatol; 2010 Aug; 19(8):e302-5. PubMed ID: 19845760
[TBL] [Abstract][Full Text] [Related]
20. The time-dependent accumulation of protoporphyrin IX fluorescence in nodular basal cell carcinoma following application of methyl aminolevulinate with an oxygen pressure injection device.
Blake E; Campbell S; Allen J; Mathew J; Helliwell P; Curnow A
J Photochem Photobiol B; 2012 Dec; 117():97-103. PubMed ID: 23092624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
